IL10 and neoplasm: Wang et al. analyzed the same polymorphisms and reported significantly higher IL-10 mRNA levels in patients with non-small cell lung cancer with the non-ATA haplotype, showing the association of cytokine IL-10 expression levels with tumor progression [49].